Originally used to help treat type 2 diabetes, these medications have gained in popularity over the last few years for weight loss
Knowing the exact concentration is essential for accurate dosing
However, this would represent an off-label, experimental approach that falls well outside current NICE guidance or standard NHS practice, and should only ever be considered within a formal clinical trial or with robust multidisciplinary oversight, documented informed consent, and a clear monitoring plan
Retatrutide , a triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, has shown weight loss results exceeding those of current dual-agonists
What are the four stages of Vitamin B12 deficiency